• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Sunalene Devadason

    Sunalene Devadason

    Sunalene Devadason

    The University of Western Australia
    Perth, Australia

    My current position is as Academic Coordinator, Graduate Research at the Division of Paediatrics in the Medical School at the University of Western Australia. My primary research focus is in aerosol therapy for the treatment of paediatric respiratory disease utilizing in vivo techniques such as gamma scintigraphy as well as in vitro assessments of drug delivery and inhalation techniques in children. I have been an ISAM Board member since 2005, serving as General Secretary from 2009 to 2013, and as President from 2013 to 2015. I’m currently completing my term as Past President and will complete my tenure on the Board at the 2019 ISAM Congress.

    Device Selection, Training and Adherence: Pediatric Considerations


    The majority of devices used for inhalation therapy have been designed with older children and adults in mind. While problems with compliance and dose variability with inhaler therapy do occur in these patients, the problems are magnified when these devices are used in young children. Added to this are a very unique set of considerations associated with choosing an appropriate aerosol device for use in infants and toddlers. Of the wide variety of aerosol devices currently available, very few are suitable for use in this age group. In general, infants and toddlers (0–3 years) can only inhale drug using tidal breathing with a face mask. This largely limits the choice of inhaler device in this age group to nebulizers or pressurized metered dose inhalers (pMDIs) with spacers.